HIV
and AIDS
Human Immunodeficiency Virus and
Acquired Immunodeficiency Syndrome
current September 2007
HIV/AIDS Therapeutics
- Antiretroviral drugs used in the
treatment of HIV infection
- Approved generic formulations
of antiretroviral drugs used in the treatment of HIV infection
- Approved therapies for the treatment
of complications of HIV/AIDS
- Approved antiretroviral drugs for
pediatric treatment of HIV infection
- Approved medical devices for the
treatment of complications of HIV/AIDS
- HIV and AIDS - Medicines
to Help You. Easy-to-read basic information
about FDA-approved medicines for treating HIV/AIDS
- Expanded Access and Expedited Approval
of New Therapies Related to HIV/AIDS
- HIV/AIDS Treatment INDs Allowed
to Proceed
- Current
HIV treatment guidelines
The U.S. Department of Health and Human Services issues guidance documents for
the medical management of HIV infection and other issues surrounding HIV infection.
Includes guidelines for antiretroviral treatment, maternal-child transmission,
post-exposure prophylaxis, management of HIV complications, testing, and archived
guidelines.
- Antiretroviral Reference Tables for Clinicians
Reference charts showing possible dose adjustments for the following
(1) interacting antiretroviral medications, (2) adult dosing for ritonavir-boosted
protease inhibitors, (3) options for once-daily dosing of antiretrovirals,
(4) dosing of antiretroviral drugs in renal insufficiency and hemodialysis,
and summaries of the most common and most serious adverse events associated
with antiretroviral medications used to treat HIV infection. (HSRA AIDS
Education and Training Centers)
- MedWatch - FDA's voluntary system
for reporting adverse drug events
The Medwatch program enhances the effectiveness of postmarketing surveillance
of medical products as they are used in clinical practice, helping
to rapidly identify significant health hazards associated with these
products. Visit
the MedWatch page to find medical product safety alerts and related
information, or to learn how to work with your health care professional
to report possible adverse reactions. The
identity of the patient is kept confidential.
- "MedWatch: FDA's 'Heads
Up' on Medical Product Safety"
An FDA Consumer article discussing the MedWatch program to improve
the safety of drugs, biologics, medical devices, dietary supplements,
medical foods, infant formulas, and other regulated products by encouraging
health care professionals to report serious adverse events and product
defects. (November-December 1998)
HIV/AIDS
Home Page
